NCT06047808

Brief Summary

The death of a child, at any age, is considered one of the most stressful life events a person can experience. In 2020, 11,050 children (under 15 years), 5,000 adolescents (15-19 years) and 60,000 young adults (20-39 years) were estimated to be diagnosed with cancer in the US. While the five-year survival is better for children than adults, over 10,000 children, adolescents, and young adults die from cancer in the US each year.1 Bereaved parents often experience intense and lasting psychological distress resulting in significantly higher morbidity and mortality compared to non-bereaved parents. Twenty-five percent of bereaved parents report new diagnoses of illnesses including prediabetes, anxiety and sleep disorders. Bereaved parents also experience psychological distress such as anxiety, post-traumatic stress disorder, and grief-related depressive symptoms that continue to be significant for years after a child's death. A recent study showed that nearly 33% of bereaved parents suffered from prolonged grief five years after their loss.6 Physiologically, studies show increased cortisol, immune, endocrine, and cardio biomarkers in people with prolonged grief. The death of a child can also affect family and social relationships resulting in decreased communication, feelings of isolation, absence of close social relationships and increased marital strain and divorce. The purpose of this randomized controlled pilot study is to evaluate the feasibility of implementing a six-week multi-dimensional intervention, Storytelling Through Music (STM), with parents of children who have died from cancer. STM combines multiple modalities of expression (storytelling, writing, and music) to facilitate loss- and restoration-oriented coping by creating a legacy piece (self-written story paired with song) to facilitate continuing bonds with the deceased and find meaning.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 6, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

September 21, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2024

Completed
Last Updated

March 13, 2025

Status Verified

November 1, 2024

Enrollment Period

1.2 years

First QC Date

June 6, 2023

Last Update Submit

March 10, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Study Feasibility

    Feasibility will be evaluated by tracking the percentage of participants screened and enrolled. The study will be deemed feasible with a 60% enrollment rate.

    Immediately post-intervention (6 weeks)

  • Intervention Feasibility

    Feasibility will be evaluated by tracking the average number of sessions the participants complete. This intervention will be deemed feasible if 85% of the intervention is completed.

    Immediately post-intervention (6 weeks)

  • Intervention Acceptability

    An additional primary endpoint is acceptability. Acceptability will be evaluated with semi-structured interview questions to understand the participant's perception of intervention delivery and content, as well as the perceived impact.

    Immediately post-intervention (6 weeks)

Secondary Outcomes (9)

  • Mean Change from Baseline in Anxiety Scores at 6 weeks and 10 weeks

    Immediately post-intervention and 1-month post-intervention

  • Mean Change from Baseline in Depression Scores at 6 weeks and 10 weeks

    Immediately post-intervention and 1-month post-intervention

  • Mean Change from Baseline in Quality of Life Scores at 6 weeks and 10 weeks

    Immediately post-intervention and 1-month post-intervention

  • Mean Change from Baseline in Sleep Disturbance Scores at 6 weeks and 10 weeks

    Immediately post-intervention and 1-month post-intervention

  • Mean Change from Baseline in Loneliness Scores at 6 weeks and 10 weeks

    Immediately post-intervention and 1-month post-intervention

  • +4 more secondary outcomes

Study Arms (2)

Storytelling Through Music

EXPERIMENTAL

Participants will be randomized to either the "Storytelling Through Music" (STM) experimental arm or the waitlist control arm. STM is a six-week intervention that utilizes storytelling, reflective writing, self-care skills (i.e., breathing exercises, meditation, self-compassion, body scans), and songwriting. The intervention is delivered online and in a group setting. Online delivery provides convenience to participants, and the group setting provides an environment of people with shared experiences, which has been shown to decrease social isolation and feelings of being alone in their emotional experience. By the end of the intervention, participants will have written a short story and a song based on their story.

Behavioral: Storytelling Through Music

Waitlist Control

NO INTERVENTION

Participants will receive the same "Storytelling Through Music" intervention once data collection from the experimental arm is complete.

Interventions

"Storytelling Through Music" is a six-week expressive arts intervention.

Storytelling Through Music

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \>18 years old
  • able to read and speak English
  • bereaved parent of a child who died from cancer (ages\<39 years)
  • child's death \>6 months and \<5 years before study initiation
  • access to the internet and computer.

You may not qualify if:

  • do not have the technological requirements for Zoom interviews and REDCap surveys.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Texas at Austin

Austin, Texas, 78712, United States

Location

MeSH Terms

Conditions

NeoplasmsPsychological Well-Being

Condition Hierarchy (Ancestors)

Personal SatisfactionBehavior

Study Officials

  • Carolyn Phillips, PhD

    University of Texas at Austin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 6, 2023

First Posted

September 21, 2023

Study Start

May 1, 2023

Primary Completion

July 30, 2024

Study Completion

July 30, 2024

Last Updated

March 13, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations